Effects of acetylsalicylic acid and acetic acid solutions on VX2 liver carcinoma in rabbits: in vivo analysis

Saad-Hossne, Rogério; Prado, René Gamberini; Hossne, William Saad.
Acta cir. bras ; 22(4): 299-308, July-Aug. 2007. tab, ilus
Artigo em Inglês | LILACS, VETINDEX | ID: biblio-1456198

Documentos relacionados

  1. Aspirin use is associated with reduced risk for hepatocellular carcinoma.
  2. Aspirin Use and the Risk of Liver Cancer.
  3. Synthesis of Tropine-Based Functionalized Acidic Ionic Liquids and Catalysis of Esterification.
  4. Aspirin for Metabolic Dysfunction-Associated Steatotic Liver Disease Without Cirrhosis: A Randomized Clinical Trial.
  5. Aspirin and cancer treatment: systematic reviews and meta-analyses of evidence: for and against.
  6. Aspirin Use and the Risk of Hepatocellular Carcinoma: A Meta-analysis.
  7. Aspirin triggers ferroptosis in hepatocellular carcinoma cells through restricting NF-κB p65-activated SLC7A11 transcription.
  8. A closer look at endothelial injury-induced platelet hyperactivity and the use of aspirin in the treatment of COVID infection.
  9. Does aspirin reduce the incidence, recurrence, and mortality of hepatocellular carcinoma? A GRADE-assessed systematic review and dose-response meta-analysis.
  10. Biochemical and pathophysiological improvements in rats with thioacetamide induced-hepatocellular carcinoma using aspirin plus vitamin C.